A model for predicting overall survival in men with metastatic castrate-resistant prostate cancer (CRPC) for whom first-line chemotherapy failed.
Susan Halabi
Research Funding - Sanofi
Chen-Yen Lin
No relevant relationships to disclose
Eric Jay Small
No relevant relationships to disclose
Andrew J. Armstrong
Consultant or Advisory Role - Bayer
Research Funding - Janssen Pharmaceutical ; Medivation; Sanofi
Other Remuneration - Sanofi
Ellen B. Kaplan
No relevant relationships to disclose
Daniel Peter Petrylak
Consultant or Advisory Role - Sanofi
Research Funding - Sanofi
Cora N. Sternberg
Consultant or Advisory Role - Sanofi
Liji Shen
Employment or Leadership Position - Sanofi
Stephane Oudard
Honoraria - Bayer; Keocyt; Novartis; Pfizer; Roche; Sanofi
Johann Sebastian De Bono
Honoraria - Sanofi
Research Funding - Sanofi
A. Oliver Sartor
Consultant or Advisory Role - Sanofi
Research Funding - Sanofi